Dolby Laboratories Insiders Sell US$2.6m Of Stock, Possibly Signalling Caution
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Rosenblatt Securities Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $95
Barrington Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $100
Research Alert: CFRA Lowers Opinion On Shares Of Dolby Laboratories, Inc. To Sell From Hold
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target
Dolby Laboratories Analyst Ratings
William Blair Initiates Dolby Laboratories(DLB.US) With Buy Rating
Dolby Laboratories: Resilience and Growth Amid Economic Challenges
Dolby Laboratories Fiscal Q2 Adjusted Earnings, Revenue Rise
Rosenblatt Securities Maintains Dolby Laboratories(DLB.US) With Buy Rating, Cuts Target Price to $95
Earnings Call Summary | Dolby Laboratories(DLB.US) Q2 2025 Earnings Conference
Rosenblatt Securities Keeps Their Buy Rating on Dolby Laboratories (DLB)
Dolby Laboratories To Go Ex-Dividend On May 13th, 2025 With 0.33 USD Dividend Per Share
DOLBY LABORATORIES Earnings Results: $DLB Reports Quarterly Earnings
Research Alert: Dlb Results Exhibiting Signs Of Weakening Electronics Demand
Dolby Laboratories Reports $352 Million Still Available Under Buyback Program
Express News | Dolby Laboratories Sees Q3 GAAP EPS $0.26-$0.41 Vs $0.46 Est
Dolby Laboratories | 10-Q: Q2 2025 Earnings Report
Dolby Laboratories Sees 3Q Gross Margins of Approximately 86% on a GAAP Basis, Approximately 88% on a Non-GAAP Basis >DLB